Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Taylor

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 27, 2024
The impact of depression and childhood maltreatment experiences on psychological adaptation from lockdown to reopening period during the COVID-19 pandemicJulian Herpertz, Janik Goltermann, Marius Gruber, et al.
Molecular Psychiatry|March 31, 2024
Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disordersAnders Kämpe, Jaana Suvisaari, Markku Lähteenvuo, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
Clinical Genitourinary Cancer|September 27, 2024
Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial CarcinomaJason Zappia, Courtney Yong, James Slaven, et al.
Nature Genetics|May 16, 2017
Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disordersDaniel J Weiner, Emilie M Wigdor, Stephan Ripke, et al.
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
Urologic Oncology|February 16, 2025
Cumulative smoking exposure impacts oncologic outcomes of upper tract urothelial carcinomaRaj Bhanvadia, Emily Bochner, Benjamin Popokh, et al.
BJU International|October 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancerMarkus von Deimling, Marc Furrer, Laura S Mertens, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
Molecular Cancer Therapeutics|November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical StudiesEkta Patel, Natalia V Malkova, David Crowe, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 27, 2024
The impact of depression and childhood maltreatment experiences on psychological adaptation from lockdown to reopening period during the COVID-19 pandemicJulian Herpertz, Janik Goltermann, Marius Gruber, et al.
Molecular Psychiatry|March 31, 2024
Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disordersAnders Kämpe, Jaana Suvisaari, Markku Lähteenvuo, et al.
European Urology Oncology|December 18, 2024
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive Non-Muscle Invasive Bladder CancerJacob Taylor, Ashish M Kamat, Drupad Annapureddy, et al.
Clinical Genitourinary Cancer|September 27, 2024
Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial CarcinomaJason Zappia, Courtney Yong, James Slaven, et al.
Nature Genetics|May 16, 2017
Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disordersDaniel J Weiner, Emilie M Wigdor, Stephan Ripke, et al.
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
Urologic Oncology|February 16, 2025
Cumulative smoking exposure impacts oncologic outcomes of upper tract urothelial carcinomaRaj Bhanvadia, Emily Bochner, Benjamin Popokh, et al.
BJU International|October 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancerMarkus von Deimling, Marc Furrer, Laura S Mertens, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
Molecular Cancer Therapeutics|November 29, 2023
XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical StudiesEkta Patel, Natalia V Malkova, David Crowe, et al.
Pageof 8